| Subject: | Overview of Extensively Drug Resistant Tuberculosis |
| Category: | Centers for Disease Control and Prevention (CDC)
|
| Published: | Thu, 7 Jun 2007 - 06:00 am |
| The StayAlert Administrator has been asked to review Extensively Drug Resistant Tuberculosis (XDR TB). Extensively Drug-Resistant Tuberculosis (XDR TB) is a relatively rare type of Multi-drug Resistant Tuberculosis (MDR TB). Multi-Drug Resistant Tuberculosis (MDR TB) is Tuberculosis (TB) that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampin, the first-line drugs that are used to treat all persons with TB disease. XDR TB is resistant to the first line... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
External Links:
Related MCN Products:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|